Trial Profile
Making an "Obese" Brain (and Body) Lean: Insulin Detemir, Monoamines, and Reward.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Apr 2024
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IDIOM
- 15 Apr 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 15 Apr 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2025.
- 09 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.